4
Changes in Ownership
BECTON DICKINSON & CO Filed Acc 0001628280-26-003734
EVP, CRO & Pres. Life Sciences sold 75 shares at $202.73 ($15,205)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Feld Michael · EVP, CRO & Pres. Life Sciences
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-01-26 | Sale : show line 1 in the form 10b5-1 | −75 | $202.73 | $15,205 | 16,431 | D |
| Open-market sales · 75 sh · avg $202.73 · $15,205 | ||||||
Loading xslF345X05/wk-form4_1769611611.xml…